Effects of disease severity and necrosis on pancreatic dysfunction after acute pancreatitis

Table 1 Subjective clinical evaluation test

Age/sex:

- Did DM develop after AP?

(a) yes (b) no

- Any abdominal pain, discomfort, steatorrhea, weakness, weight loss, lack of appetite after AP?

(a) yes (b) no

- Did you use pancreatic enzyme supplementation? If so, how long time did you use it?

(a) yes (b) no

AP: Acute pancreatitis; DM: Diabetes mellitus.

Table 2 The association between disease severity and contrast enhanced computed tomography findings and exocrine dysfunction n (%)

Disease severity and CT findings	Exocrine dysfunction	Pvalue
SAP	7/39 (17.9)	NS
MAP	8/70 (11.4)	NS
NAP	8/30 (26.6)
EAP	5/54 (9.2)	NS
Normal CT	2/25 (8.0)

CT: Computed tomography; SAP: Severe acute pancreatitis; MAP: Mild acute pancreatitis; NAP: Necrotizing acute pancreatitis; EAP: Edematous acute pancreatitis; NS: Not significant.